Skip to content
healthcare.dev

Levalbuterol

NDC 81894-102, Levalbuterol, solution, from Luoxin Aurovitas Pharma (Chengdu) Co., Ltd..

Product NDC
81894-102
Status
Listed
Labeler
Luoxin Aurovitas Pharma (Chengdu) Co., Ltd.
Dosage form
SOLUTION
Route
RESPIRATORY (INHALATION)
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA207625
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/81894-102 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LEVALBUTEROL HYDROCHLORIDE.63 mg/3mL

Pharmacologic classes

Adrenergic beta2-Agonists [MoA]; beta2-Adrenergic Agonist [EPC]

Package NDCNDC-11Package
81894-102-25818940102255 POUCH in 1 CARTON (81894-102-25) / 5 VIAL, SINGLE-DOSE in 1 POUCH (81894-102-05) / 3 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/29eae75d-93da-7a5a-e063-6394a90ac0c0

Use it

Look up 81894-102 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/81894-102 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 81894-102. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.